170 related articles for article (PubMed ID: 11737438)
1. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.
Wolf JE; Taylor JR; Tschen E; Kang S
Int J Dermatol; 2001 Nov; 40(11):709-13. PubMed ID: 11737438
[TBL] [Abstract][Full Text] [Related]
2. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.
Rivers JK; Arlette J; Shear N; Guenther L; Carey W; Poulin Y
Br J Dermatol; 2002 Jan; 146(1):94-100. PubMed ID: 11841372
[TBL] [Abstract][Full Text] [Related]
3. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
Jarvis B; Figgitt DP
Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
5. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
Nelson C; Rigel D; Smith S; Swanson N; Wolf J
J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study.
Fariba I; Ali A; Hossein SA; Atefeh S; Atarzadeh Behbahan SA
Indian J Dermatol Venereol Leprol; 2006; 72(5):346-9. PubMed ID: 17050927
[TBL] [Abstract][Full Text] [Related]
7. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
[TBL] [Abstract][Full Text] [Related]
8. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses.
Gebauer K; Brown P; Varigos G
Australas J Dermatol; 2003 Feb; 44(1):40-3. PubMed ID: 12581080
[TBL] [Abstract][Full Text] [Related]
9. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies.
Pirard D; Vereecken P; Mélot C; Heenen M
Arch Dermatol Res; 2005 Nov; 297(5):185-9. PubMed ID: 16235081
[TBL] [Abstract][Full Text] [Related]
10. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
Rivers JK
Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
[TBL] [Abstract][Full Text] [Related]
11. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
[TBL] [Abstract][Full Text] [Related]
13. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Rivers JK; McLean DI
Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
[TBL] [Abstract][Full Text] [Related]
14. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
Van der Geer S; Krekels GA
J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
[TBL] [Abstract][Full Text] [Related]
15. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
Stockfleth E; Kerl H; Zwingers T; Willers C
Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
[TBL] [Abstract][Full Text] [Related]
16. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
Ulrich M; Pellacani G; Ferrandiz C; Lear JT
Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
Berlin JM; Rigel DS
J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
[TBL] [Abstract][Full Text] [Related]
18. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
[TBL] [Abstract][Full Text] [Related]
19. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
Burkhart CN; Burkhart CG
Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
[No Abstract] [Full Text] [Related]
20. Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety.
Javor S; Cozzani E; Parodi A
G Ital Dermatol Venereol; 2016 Jun; 151(3):275-80. PubMed ID: 26512929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
